Who we are

We are the global Data Space Mediator that securely and compliantly activates healthcare data using Artificial Intelligence, and mediate between data holders and data users ensuring a compliant exchange of data for secondary uses

We want to change Healthcare forever

At IOMED, we aim to lay the foundation for data-driven medicine and ensure that medical practice is based on evidence and real-world data. Our aspiration is to become catalysts for change and achieve more personalized and effective healthcare. In this way, we work tirelessly to make medical information more accessible and valuable to the community.

21M+

Unique medical records

50+

Strategic partners

30+

Years of data

40+

Research projects

450K+

Impacted patients

Our values and principles

Transparency

We strive to be open and honest in all our interactions. We communicate clearly and directly with our collaborators, clients, and partners, ensuring that we share relevant and truthful information.

Loyalty

We maintain unwavering loyalty to our clients, partners, and team members. We value long-term relationships and work to build strong bonds based on mutual trust and respect.

Rigor

This drives us to maintain high standards of quality in our services. We seek precision and accuracy in the development of our technology, ensuring that our results are precise, reliable, and rigorous.

Commitment

We are committed to making a positive impact in the field of health and biotechnology, being the key ally to build a data-driven healthcare ecosystem.

One step at a time

Our history

2014 - The idea

In 2014, Gabriel de Maeztu identified a crucial need while researching. He needed to improve efficiency data collection and patient recruitment.

2017 - IOMED was born

IOMED's founders embarked on the development and launching of an AI-technology to cover this gap in healthcare ecosystem.

2020 - Exponential growth

Initially deployed in hospitals in Barcelona, IOMED's success quickly drove its expansion nationwide.

2023 Internationalization

Shortly thereafter, the company experienced significant growth in less than six years, and now faces a new challenge: expand its technology through Europe.

What's new
‍

October 18, 2024

Mats Sundgren, IOMED’s Scientific Advisor, presents a keynote at the Festival of Biologics

Mats Sundgren, IOMED’s Scientific Advisor, proudly participated in the Festival of Biologics 2024, where industry leaders gathered to explore cutting-edge innovations in clinical research. Highlighting the transformative power of Real-World Data and AI, this event underscored the future of biologics and its impact on patient care.

October 11, 2024

IOMED celebrates the success of EHDEN IHI 2 project at the EHDEN Symposium 2024

Held on October 9-10, 2024, the symposium brought together key stakeholders from across the European health data landscape at a crucial moment for the future of collaborative health research and data use.

August 8, 2024

Transforming Clinical Research with IOMED: Depth and Efficiency in Real-World Data (RWD)

IOMED stands out as a leader in the field of clinical research through the development and application of artificial intelligence to enhance precision and efficiency in clinical trials.